Several have taken a stab at PPS of MDXG. Most of us believe MDXG will be bought out at some point and revenues will see benefit from Medtronic deal and increasing US market share. Based on probable revenues for 2014, I am projecting PPS of 12-15 per share for 2014 with buyout in 2015 16-30 likely around 22. I had to say it prior to end 2013 and this information along with $175 in Marietta, GA gets you a tall at Starbucks.
I predict MiMedx takes out the old 52 week high of $8.73 and puts in a new 52 week high on December 31, 2013. $8.85 would represent a $5 increase from the $3.85 closing price on December 31, 2012.
Sorry to digress. I realize you were looking for 2014 and 2015 projections, but we still have one final trading day left in 2013. A close above $9 would be sweet. A close above $10 would vindicate the old_wise_one and be even better!
I think the stock triples from here and the company gets sold in the next 18 months for about $25, but I'm more curious now about December 31, 2013.
As previously posted, we're out of here at $15 to $20 late 2014 or early 2015. I would welcome the opportunity to ride this horse longer but think a buyout soon is the most likely outcome.
I'd like to know how the SEC investigation of Petit is proceeding. I'll buy Pete's side of the story in a heart beat but it has to be aggravating, time consuming and expensive. The SEC has had some major losses in the matters recently that played big time in the press, yet they continue to bring BS cases.
One should not assume a buyout. MDXG would benefit more as a stand alone company with a solid balance sheet and product pipeline. This company and its seasoned management team realizes its products full potential (ref MDXG conference calls). selling prematurely would be foolish.
while not strictly a device, look at the device sector. Generally most small firms get bought out by a limited number of larger players. Not sure this will happen here but the probability seems high. sc4